Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan Young currently holds 200,189 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Young has been a net seller of AKRO stock. They have purchased $0 and sold $6.6M worth of shares.
Jonathan Young's most recent insider trade was on Dec 9, 2025, when they sold 152,616 shares at $0.00 per share.
Jonathan Young serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 79 insider transactions totaling $6.6M over their tenure at the company.
Jonathan Young holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Jonathan Young has shown a selling trading pattern, with $0 in total purchases and $6.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jonathan Young was on Aug 12, 2025, when they sold $532.1K worth of AKRO shares. This transaction involved 11,151 shares at $47.72 per share.
Jonathan Young currently owns 200,189 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan Young's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan Young has 79 Form 4 filings on record as an insider at Akero Therapeutics, Inc..
Set alerts for Jonathan Young and 40,000+ other insiders.